1. Committee for Medicinal Products for Human Use (CHMP). Guideline on Similar Biologic Medicinal Products Containing Monoclonal Antibodies-Non-Clinical and Clinical Issues. EMA/CHMP/BMWP/403543/2010. May 30, 2012;European Medicines Agency,2012
2. Biosimilars—why terminology matters;Weise;Nat. Biotechnol.,2011
3. AIFA Position Paper. I farmaci biosimilari. Issued 13 May 2013, http://www.agenziafarmaco.gov.it/sites/default/files/AIFA_POSITION_PAPER_FARMACI_BIOSIMILARI.pdf (Accessed 14 July 2017).
4. Acceptable changes in quality attributes of glycosylated biopharmaceuticals;Schiestl;Nat. Biotechnol.,2011
5. An innovative approach for the characterization of the isoforms of a monoclonal antibody product;Sundaram;MAbs,2011